NTC
North Tide Capital Portfolio holdings
AUM
$469M
This Quarter Return
+12.33%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$1.32B
AUM Growth
+$1.32B
(-11%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-23.38%
Top 10 Holdings %
Top 10 Hldgs %
73.44%
Holding
28
New
3
Increased
5
Reduced
7
Closed
8
Top Buys
| 1 |
Community Health Systems
CYH
|
$78.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$43.4M |
| 3 |
Baxter International
BAX
|
$34.3M |
| 4 |
KND
Kindred Healthcare
KND
|
$12.2M |
| 5 |
AFAM
Almost Family Inc
AFAM
|
$7.13M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$93.5M |
| 2 |
Quest Diagnostics
DGX
|
$67.1M |
| 3 |
Bausch Health
BHC
|
$49.7M |
| 4 |
WW
WW International
WW
|
$42.2M |
| 5 |
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
|
$38.1M |
Sector Composition
| 1 | Healthcare | 82.51% |
| 2 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Select Medical
SEM
$1.61B
| $199M | 15.09% | 13,450,000 -500,000 | -4% | -$7.42M |
|
|
KND
2
DELISTED
Kindred Healthcare
KND
| $131M | 9.92% | 5,513,999 +513,999 | +10% | +$12.2M |
|
|
AMED
3
DELISTED
Amedisys
AMED
| $107M | 8.1% | 4,000,000 | – | – |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $93.5M | 7.07% | 1,500,000 -1,500,000 | -50% | -$93.5M |
|
|
SVU
5
DELISTED
SUPERVALU Inc.
SVU
| $81.4M | 6.16% | 7,000,000 +500,000 | +8% | +$5.82M |
|
6
Boston Scientific
BSX
$156B
| $79.9M | 6.04% | 4,500,000 -500,000 | -10% | -$8.88M |
|
|
7
Community Health Systems
CYH
$387M
| $78.4M | 5.93% | +1,500,000 | New | +$78.4M |
|
|
TVTY
8
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $75.8M | 5.74% | 3,850,000 | – | – |
|
9
Orthofix Medical
OFIX
$592M
| $64.6M | 4.89% | 1,800,000 | – | – |
|
10
Viatris
VTRS
$12.3B
| $59.4M | 4.49% | 1,000,000 -500,000 | -33% | -$29.7M |
|
|
AFAM
11
DELISTED
Almost Family Inc
AFAM
| $55.9M | 4.23% | 1,250,000 +159,500 | +15% | +$7.13M |
|
|
12
Bausch Health
BHC
$2.74B
| $49.7M | 3.76% | 250,000 -250,000 | -50% | -$49.7M |
|
|
GHDX
13
DELISTED
Genomic Health, Inc.
GHDX
| $45.8M | 3.47% | 1,500,000 | – | – |
|
|
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
| $43.4M | 3.28% | +500,000 | New | +$43.4M |
|
|
ELOS
15
DELISTED
Syneron Medical Ltd
ELOS
| $37.1M | 2.81% | 3,000,000 | – | – |
|
|
MGLN
16
DELISTED
Magellan Health Services, Inc.
MGLN
| $35.4M | 2.68% | 500,000 -200,000 | -29% | -$14.2M |
|
|
17
Baxter International
BAX
$12.7B
| $34.3M | 2.59% | +500,000 | New | +$34.3M |
|
|
VVUS
18
DELISTED
Vivus Inc
VVUS
| $30.8M | 2.33% | 12,500,000 +1,195,200 | +11% | +$2.94M |
|
|
FRED
19
DELISTED
Fred's Inc
FRED
| $10.9M | 0.83% | 638,900 -861,100 | -57% | -$14.7M |
|
|
AEGR
20
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $7.85M | 0.59% | 300,000 +100,000 | +50% | +$2.62M |
|
21
AbbVie
ABBV
$372B
| – | – | -500,000 | Closed | -$32.7M |
|
22
Accuray
ARAY
$157M
| – | – | -2,000,000 | Closed | -$15.1M |
|
|
23
Quest Diagnostics
DGX
$20.3B
| – | – | -1,000,000 | Closed | -$67.1M |
|
24
Myriad Genetics
MYGN
$593M
| – | – | -1,100,000 | Closed | -$37.5M |
|
|
WW
25
DELISTED
WW International
WW
| – | – | -1,700,000 | Closed | -$42.2M |
|